KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Receivables - Other (2016 - 2021)

Historic Receivables - Other for Quest Diagnostics (DGX) over the last 9 years, with Q1 2021 value amounting to $5.0 million.

  • Quest Diagnostics' Receivables - Other changed 0.0% to $5.0 million in Q1 2021 from the same period last year, while for Mar 2021 it was $5.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.0 million for FY2020, which is 2500.0% down from last year.
  • According to the latest figures from Q1 2021, Quest Diagnostics' Receivables - Other is $5.0 million, which was down 0.0% from $3.0 million recorded in Q4 2020.
  • Quest Diagnostics' 5-year Receivables - Other high stood at $13.0 million for Q2 2017, and its period low was $3.0 million during Q4 2017.
  • For the 5-year period, Quest Diagnostics' Receivables - Other averaged around $4.9 million, with its median value being $4.0 million (2018).
  • Its Receivables - Other has fluctuated over the past 5 years, first skyrocketed by 8333.33% in 2017, then crashed by 7692.31% in 2018.
  • Quest Diagnostics' Receivables - Other (Quarter) stood at $3.0 million in 2017, then changed by 0.0% to $3.0 million in 2018, then surged by 33.33% to $4.0 million in 2019, then dropped by 25.0% to $3.0 million in 2020, then soared by 66.67% to $5.0 million in 2021.
  • Its last three reported values are $5.0 million in Q1 2021, $3.0 million for Q4 2020, and $4.0 million during Q3 2020.